Body weight categories and fat distribution in relation to all-cause mortality among adults with metabolic dysfunction-associated steatotic liver disease: a population-based analysis of NHANES, 2007-2018.
Fat distribution patterns beyond body weight separately predict mortality in fatty liver disease patients, refining how we assess cardiometabolic risk.
Using NHANES 2007-2018 data on MASLD patients, this population-based analysis characterizes how body composition beyond BMI (fat distribution phenotype) differentially predicts all-cause mortality, with implications for cardiometabolic risk stratification in the MASLD/obesity epidemic context. Relevant to GLP-1/SGLT2 intervention targeting for MASLD prevention.
What the study was
- Study design
- Population-based cross-sectional / retrospective cohort analysis (NHANES 2007-2018)
- Population
- Adults with MASLD (metabolic dysfunction-associated steatotic liver disease) from NHANES
- Category
- Public Health
- Maturity
- Validated
- Journal
- BMJ Open
Why it surfaced
NHANES population-based data on MASLD mortality; directly relevant to GLP-1/cardiometabolic watchlist as MASLD is major endpoint in metabolic drug trials; BMJ Open.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.